Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

6.06
Delayed Data
As of Jun 23
 +0.24 / +4.12%
Today’s Change
1.51
Today|||52-Week Range
6.39
+197.06%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 5.50, with a high estimate of 8.00 and a low estimate of 1.40. The median estimate represents a -9.24% decrease from the last price of 6.06.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in ImmunoGen Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.40
Sales
$14.0M
Reporting Date
Jul 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -100.56%
 
 
 
 
 
 
Growthannually 13.67%
 
 
 
 
 
 

Sales

Growthquarterly -51.27%
 
 
 
 
 
 
Growthannually 19.38%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.